Replies to post #39078 on Itonis Inc (ITNS)

[metslinger61]

If Emesyl passes CVS trial, I see ITNS going .02-.05. Could be buyout if Emesyl goes to 8000 stores then grows to other pharmacy stores. Just like Zicam (same inventor)…this is a no brainer! Hopefully PR out soon or will publish in next quarterly report that’s due out in early July! GLTA